Log in

002742 Chongqing Jiheng Pharmaceutical Co., Ltd. SZSE · China

Chongqing Jiheng Pharmaceutical Co. (002742) news

Chongqing Jiheng Pharmaceutical Co., Ltd. is a public biotech or pharmaceutical company listed on SZSE under the ticker 002742, recorded under China. The directory classifies it as Diversified pharmaceuticals / APIs. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Chongqing Jiheng Pharmaceutical Co. news

We have not published a story on Chongqing Jiheng Pharmaceutical Co. yet. When there is news, it will appear here.

Questions about Chongqing Jiheng Pharmaceutical Co.

What is the ticker symbol of Chongqing Jiheng Pharmaceutical Co.?

Chongqing Jiheng Pharmaceutical Co., Ltd. trades under the ticker 002742 on SZSE.

Where is Chongqing Jiheng Pharmaceutical Co. listed?

Chongqing Jiheng Pharmaceutical Co., Ltd. is listed on SZSE.

Which country or territory is Chongqing Jiheng Pharmaceutical Co. listed under?

Our directory records Chongqing Jiheng Pharmaceutical Co., Ltd. under China.

What does Chongqing Jiheng Pharmaceutical Co. do?

Our directory classifies Chongqing Jiheng Pharmaceutical Co., Ltd. as: Diversified pharmaceuticals / APIs. This is a directory classification, not a description of the pipeline.

What is the ISIN of Chongqing Jiheng Pharmaceutical Co.?

The ISIN recorded for Chongqing Jiheng Pharmaceutical Co., Ltd. is CNE100001WZ4.

Does aibio.space cover Chongqing Jiheng Pharmaceutical Co.?

aibio.space lists Chongqing Jiheng Pharmaceutical Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Chongqing Jiheng Pharmaceutical Co.?

Companies in our directory listed in the same country and business area as Chongqing Jiheng Pharmaceutical Co.: Star Lake Bioscience Co., Pharmaron Beijing Co., Vigonvita Life Sciences Co., Shandong Boan Biotechnology Company., Limited., Fujian Haixi Pharmaceuticals Co., InnoCare Pharma.

Investor discussion: Chongqing Jiheng Pharmaceutical Co.

Members talk about Chongqing Jiheng Pharmaceutical Co. (002742). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SZSE:002742 on TradingView.

Listing details

Chongqing Jiheng Pharmaceutical Co., Ltd. is a public biotech or pharmaceutical company listed on SZSE under the ticker 002742, recorded under China. The directory classifies it as Diversified pharmaceuticals / APIs. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Chongqing Jiheng Pharmaceutical Co., Ltd.
Ticker
002742
Listing
SZSE
Country or territory
China
Business scope
Diversified pharmaceuticals / APIs
ISIN
CNE100001WZ4
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.